Last 12 months
Inside the activity.
0 purchase rows · 29 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 9 |
| Jan 2026 | 0 | 1 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 7 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 5 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 1 |
| Sep 2026 | 0 | 5 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 15, 2021 Filed Mar 17, 2021 21:28 UTC |
Cannon Stephen NChief Executive Officer · 10% owner
|
PurchaseCommon Stock | 330,000 | $10.00 | $3,300,000.00 |
DisclosureSEC source: 0001213900-21-016135 · ownership.xml · nonDerivative · entry 1 Cannon Stephen N · CIK 0001427316 · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 3,705,000 F1 · shares: The reporting person acquired units, with each unit consisting of one subunit and one-quarter of one redeemable warrant. Each subunit consists of one share of common stock of the Company, $0.0001 par value, and one-quarter of one warrant. Each whole warrant entitles the holder to purchase one share of common stock for $11.50 per share. F2 · ownership.nature: Shares owned by Archimedes Tech SPAC Sponsors LLC, over which Stephen N. Cannon shares voting and dispositive power. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.